More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

Guillermo Montalban-Bravo; Christopher B. Benton; Sa A. Wang; Farhad Ravandi; Tapan Kadia; Jorge Cortes; Naval Daver; Koichi Takahashi; Courtney Dinardo; Elias Jabbour; Gautam Borthakur; Marina Konopleva; Sherry Pierce; Carlos Bueso-Ramos; Keyur Patel; Steven Kornblau; Hagop Kantarjian; Ken H. Young; Guillermo Garcia-Manero; Michael Andreeff

doi:10.1182/blood-2016-11-749903

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

Guillermo Montalban-Bravo, Christopher B. Benton, Sa A. Wang, Farhad Ravandi, Tapan Kadia, Jorge Cortes, Naval Daver, Koichi Takahashi, Courtney Dinardo, Elias Jabbour, Gautam Borthakur, Marina Konopleva, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Steven Kornblau, Hagop Kantarjian, Ken H. Young, Guillermo Garcia-Manero, Michael Andreeff

Research output: Contribution to journal › Letter › peer-review

53 Scopus citations

Original language	English (US)
Pages (from-to)	2584-2587
Number of pages	4
Journal	Blood
Volume	129
Issue number	18
DOIs	https://doi.org/10.1182/blood-2016-11-749903
State	Published - May 4 2017

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2016-11-749903

Cite this

Montalban-Bravo, G., Benton, C. B., Wang, S. A., Ravandi, F., Kadia, T., Cortes, J., Daver, N., Takahashi, K., Dinardo, C., Jabbour, E., Borthakur, G., Konopleva, M., Pierce, S., Bueso-Ramos, C., Patel, K., Kornblau, S., Kantarjian, H., Young, K. H., Garcia-Manero, G., & Andreeff, M. (2017). More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood, 129(18), 2584-2587. https://doi.org/10.1182/blood-2016-11-749903

Montalban-Bravo, G, Benton, CB, Wang, SA , Ravandi, F , Kadia, T, Cortes, J, Daver, N , Takahashi, K , Dinardo, C , Jabbour, E , Borthakur, G, Konopleva, M, Pierce, S, Bueso-Ramos, C , Patel, K , Kornblau, S , Kantarjian, H, Young, KH, Garcia-Manero, G & Andreeff, M 2017, 'More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia', Blood, vol. 129, no. 18, pp. 2584-2587. https://doi.org/10.1182/blood-2016-11-749903

@article{bf381da4f91a4debab208ba67403d55b,

title = "More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia",

author = "Guillermo Montalban-Bravo and Benton, {Christopher B.} and Wang, {Sa A.} and Farhad Ravandi and Tapan Kadia and Jorge Cortes and Naval Daver and Koichi Takahashi and Courtney Dinardo and Elias Jabbour and Gautam Borthakur and Marina Konopleva and Sherry Pierce and Carlos Bueso-Ramos and Keyur Patel and Steven Kornblau and Hagop Kantarjian and Young, {Ken H.} and Guillermo Garcia-Manero and Michael Andreeff",

note = "Funding Information: Acknowledgments: This work was supported by the American Society of Hematology, the American Society of Hematology Research Training Award for Fellows, a grant from the National Institutes of Health, National Cancer Institute (NCI) (P30 CA016672), the Cancer Prevention Research Institute of Texas (RP100202) (G.G. M.), and generous philanthropic contributions to Anderson{\textquoteright}s AML Moon Shot Program (K.T., H.K., G.G. M., and A.F.), the NCI Leukemia Specialized Programs of Research Excellence Career Development Grant (K.T.), and the Charif Souki Cancer Research Fund.",

year = "2017",

month = may,

day = "4",

doi = "10.1182/blood-2016-11-749903",

language = "English (US)",

volume = "129",

pages = "2584--2587",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "18",

}

TY - JOUR

T1 - More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

AU - Montalban-Bravo, Guillermo

AU - Benton, Christopher B.

AU - Wang, Sa A.

AU - Ravandi, Farhad

AU - Kadia, Tapan

AU - Cortes, Jorge

AU - Daver, Naval

AU - Takahashi, Koichi

AU - Dinardo, Courtney

AU - Jabbour, Elias

AU - Borthakur, Gautam

AU - Konopleva, Marina

AU - Pierce, Sherry

AU - Bueso-Ramos, Carlos

AU - Patel, Keyur

AU - Kornblau, Steven

AU - Kantarjian, Hagop

AU - Young, Ken H.

AU - Garcia-Manero, Guillermo

AU - Andreeff, Michael

N1 - Funding Information: Acknowledgments: This work was supported by the American Society of Hematology, the American Society of Hematology Research Training Award for Fellows, a grant from the National Institutes of Health, National Cancer Institute (NCI) (P30 CA016672), the Cancer Prevention Research Institute of Texas (RP100202) (G.G. M.), and generous philanthropic contributions to Anderson’s AML Moon Shot Program (K.T., H.K., G.G. M., and A.F.), the NCI Leukemia Specialized Programs of Research Excellence Career Development Grant (K.T.), and the Charif Souki Cancer Research Fund.

PY - 2017/5/4

Y1 - 2017/5/4

UR - http://www.scopus.com/inward/record.url?scp=85028331171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028331171&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-11-749903

DO - 10.1182/blood-2016-11-749903

M3 - Letter

C2 - 28246192

AN - SCOPUS:85028331171

SN - 0006-4971

VL - 129

SP - 2584

EP - 2587

JO - Blood

JF - Blood

IS - 18

ER -

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this